The UK's largest event for private investors

Business Design Centre, London, 19 March 2022








AKL Research & Development Ltd

AKL Research & Development Limited (“AKLRD”) is a privately held, UK pharmaceutical company, with an innovative approach to drug development. AKLRD identifies secondary metabolites of plant origin with proven efficacy & safety, and which are capable of being synthesized. These synthetic metabolites then undergo standard pharmaceutical clinical development. Led by AKLRD’s expert management team providing a high level of technical, scientific and strategic skill, our innovative approach greatly increases the chances of success, while reducing the probability of unexpected side effects.

AKLRD has identified two molecules which act synergistically and have been combined to create AKL4 [APPA], a patented investigational oral medicine showing great promise in the treatment of inflammatory conditions including osteoarthritis, a highly prevalent and devastating disease with limited treatment options and no cure. Having just completed a Phase I study, a Phase II study is due to start Q2 2020.

Get your ticket

Don't miss out on the UK's largest event for private investors - secure your ticket today.

Book your stand

Join us as exhibitor and get maximum exposure to private investors.  Increase liquidity in your company's shares, generate new leads and build your brand name in the minds of the right audience.

Get in touch for a no obligation consultation.

2 + 3 =